A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00035542

Enrollment

Unknown

Registered

2002-05-06

Start date

2001-12-31

Completion date

2003-10-31

Last updated

2011-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Keywords

Diabetes Mellitus, Type II

Brief summary

The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.

Interventions

DRUGGlucovance (metformin HCl/glyburide)

DRUGmetformin HCl

DRUGglyburide

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

9 Years to 16 Years

Healthy volunteers

Inclusion criteria

Children ages 9-16 years with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, with or without oral hypoglycemic therapy, and have an HbA1c greater than 6.4%

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026